CES1 and SLC6A2 Genetic Variants As Predictors of Response To Methylphenidate in Autism Spectrum Disorders

PURPOSE: Autistic spectrum disorders (ASD) children and adolescents usually present comorbidities, with 40–70% of them affected by attention deficit hyperactivity disorders (ADHD). The first option of pharmacological treatment for these patients is methylphenidate (MPH). ASD children present more si...

Descripción completa

Detalles Bibliográficos
Autores principales: Hernandez, Marta H, Bote, Valentin, Serra-LLovich, Alexandre, Cendros, Marc, Salazar, Juliana, Mestres, Conxita, Guijarro, Silvina, Alvarez, Aida, Lamborena, Cristina, Mendez, Iria, Sanchez, Bernardo, Hervas, Amaia, Arranz, Maria J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9653043/
https://www.ncbi.nlm.nih.gov/pubmed/36393977
http://dx.doi.org/10.2147/PGPM.S377210

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9653043/
https://www.ncbi.nlm.nih.gov/pubmed/36393977
http://dx.doi.org/10.2147/PGPM.S377210

Ejemplares similares